MRX 3
Latest Information Update: 08 Mar 2013
At a glance
- Originator Morria Biopharmaceuticals
- Class Anti-inflammatories; Antiasthmatics
- Mechanism of Action Arachidonic acid inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 14 Sep 2005 Preclinical trials in Asthma prevention in Israel (Inhalation)
- 14 Sep 2005 Preclinical trials in Asthma prevention in United Kingdom (Inhalation)